Diabetes eye disease natural progression study
Part of Eyes & vision clinical trials.
This study follows people with type 2 diabetes to understand how diabetic retinopathy (an eye disease caused by diabetes) changes over time without treatment. It may help if you have no other eye issues causing new blood vessels and are not planning for certain eye procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old and have type 2 diabetes.
- You can attend clinic visits and sign a consent form.
- You have no other eye diseases that cause new blood vessel growth in the retina.
- You have no severe clouding in your eye (like cataracts) that would blur photos of your retina.
- You have not had laser treatment in your eye, or do not need it in the next six months.
- You have not had any injections into your eye (for treatment), and do not expect any in the next six months.
- You have no swelling in the center of your retina from diabetes (macular edema) at specific thickness measures.
- Your diabetic retinopathy is at a mild or moderate stage, not severe (non-proliferative).
- You have not had any eye surgery.
- You do not have kidney failure.
- You have not received any anti-VEGF (eye growth blocker) medicines through your veins in the last month.
- You do not live far away or have a detached retina that makes follow-up visits hard.
- You have no known allergies to study-related materials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a targeted laser treatment guided by a special eye scan can slow the progression of blocked blood vessels in the retina for people with diabetes-related eye disease. It may help preserve vision by treating damaged areas before they worsen.
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
This study observes how diabetes affects vision over time in people with diabetes. It helps doctors better understand eye health without any treatment or intervention.
This study tests whether advanced eye imaging can predict how diabetic eye disease (retinopathy) may worsen over time. If you have type 2 diabetes and early to moderate diabetic retinopathy without swelling in the central part of the retina, you may be able to join.
This study looks at early damage to the retina (the back of the eye) in people with type 2 diabetes, even before vision problems start. It aims to find new ways to detect and treat diabetic eye disease early.
Hear when a new Biomarkers of Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.